1. Home
  2. Vol 29, No 12s (2025)
  3. Zhang

Artificial intelligence in cancer diagnostics: Governance for equity in low- and middle-income countries

Yili Zhang(1), Dongli Peng(2), Aili Zhang(3),


(1) School of Business, Nanfang College, Guangzhou, Guangzhou,510970, China
(2) School of business,Wuxi Taihu University, Wuxi,Jiangsu , 214000, China
(3) Lyceum of the Philippines University, Manila, 0900, Philippines
Corresponding Author

Abstract


Artificial intelligence (AI) is rapidly reshaping cancer diagnostics by enhancing accuracy, speed, and clinical decision support. However, its adoption in low- and middle-income countries (LMICs) raises critical governance challenges related to data protection, regulatory oversight, equity, and infrastructural readiness. This quantitative scoping review synthesizes evidence from 19 studies published between 2015 and 2024 to map the governance landscape surrounding AI-driven cancer diagnostics in LMICs. Following the PRISMA-ScR approach, the review identified key governance domains including data sovereignty, regulatory gaps, algorithmic transparency, infrastructural constraints, and risks of inequitable access. Results indicate that data governance challenges were the most frequently reported (n=14), followed by regulatory limitations (n=12) and workforce and infrastructural barriers (n=11). The findings highlight that while AI holds transformative potential for improving timely and accurate cancer diagnosis, its benefits cannot be realized without context-sensitive governance frameworks that ensure safety, transparency, accountability, and equity. The review proposes actionable policy pathways to support responsible AI integration across LMIC health systems

References


World Health Organization. Ethics and governance of artificial intelligence for health: WHO guidance. 2021.

Bamodu OA and Chung CC. Cancer care disparities: overcoming barriers to cancer control in low-and middle-income countries. JCO Global Oncology. 2024;10: e2300439.

Topol E. High-performance medicine: The convergence of human and artificial intelligence. Nature Medicine. 2019; 25:44–56.;

Hosny A, Parmar C, Quackenbush J, Schwartz LH and Aerts HJ. Artificial intelligence in radiology. Nature Reviews Cancer. 2018; 18(8): 500–510.

Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, Thrun S. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017; 542 (7639): 115–118.

Florati L, Cowls J, King TC and Taddeo M. How to design AI for social good: seven essential factors. In: M. Dubber, F. Pasquale, and S. Das, eds. The Oxford Handbook of Ethics of AI. Oxford, UK: Oxford University Press; 2020:125-151.

McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H and Shetty S. International evaluation of an AI system for breast cancer screening. Nature. 2020; 577(7788): 89-94.

Mehrabi N, Morstatter F, Saxena N, Lerman K and Galstyan A. A survey on bias and fairness in machine learning. ACM computing surveys (CSUR). 2021; 54(6): 1-35.

Campanella G, Hanna MG, Geneslaw L, Miraflor A, Werneck Krauss Silva V, Busam KJ and Fuchs TJ. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nature medicine. 2019; 25(8): 1301-1309.

Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV and Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Computational and structural biotechnology journal. 2015; 13: 8-17.

Salathé M, Wiegand T and Wenzel M. Focus group on artificial intelligence for health. arXiv preprint arXiv: 1809.04797. 2018.

Whitelaw S, Mamas MA, Topol E and Van SHG. Applications of digital technology in COVID-19 pandemic planning and response. The Lancet Digital Health. 2020; 2(8): e435-e440.

Schönberger D. Artificial intelligence in healthcare: a critical analysis of the legal and ethical implications. International Journal of Law and Information Technology, 2019; 27(2), pp.171-203.

Veinot TC, Mitchell H and Ancker JS. Good intentions are not enough: how informatics interventions can worsen inequality. Journal of the American Medical Informatics Association. 2018; 25(8): 1080-1088.

Saria S, Butte A and Sheikh A. Better medicine through machine learning: what’s real, and what’s artificial? PLoS medicine. 2018; 15(12): e1002721.

Artificial Intelligence Act. Regulamento da União Europeia (UE). 2024; 1689.

Salathé M, Wiegand T and Wenzel M. Focus group on artificial intelligence for health. arXiv preprint arXiv:1809.04797. 2018.

Stilgoe J, Owen R and Macnaghten P. Developing a framework for responsible innovation. Research Policy. 2013; 42(9): 1568–1580.

Snyder H. Literature review as a research methodology: An overview and guidelines. Journal of business research. 2019; 104: 333-339.

Wang X, Iftikhar H, Shah U, Hashmi U and Iqbal MS. Transforming reproductive healthcare in rural China: The impact of mobile health, telemedicine, and e-health innovations on family planning and maternal health services. African Journal of Reproductive Health, 2025; 29(8s).

Wang J, Yu Y, Tan Y, Wan H, Zheng N, He Z, Mao L, Ren W, Chen K, Lin Z and He G. Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer. Nat Commun. 2024; 15:4369


Full Text: PDF

Article Metrics

Abstract View : 241 times
PDF Download : 100 times

Refbacks

  • There are currently no refbacks.